期刊文献+

树突状细胞与细胞因子诱导杀伤细胞治疗肿瘤研究进展 被引量:14

Research Progress on Dendritic Cells and Cytokine Induced Killer Cells for Cancer Treatment
下载PDF
导出
摘要 树突状细胞(dendriticcells,DC)是已知的功能最强的专职抗原提呈细胞,在抗原加工提呈、抗原识别及T细胞激活中发挥重要作用。而细胞因子诱导的杀伤细胞(cytokineinducedkillercells,CIK)是由多种细胞因子诱导而成,对多种肿瘤细胞具有杀伤作用的细胞毒性T细胞。以DC为基础的肿瘤免疫治疗日益受到人们的重视。文章就近年DC与CIK免疫治疗肿瘤的研究进展作一综述。 Dendritic cells (DC) is the most potent antigen present cells(APC). It plays an important role in antigen recognition, antigen processing presenting, and T cell activation. Cytokine induced killer cells(CIK) is induced by a few kinds of cytokines and can kill various kinds of tumor cells. The immunotherapy based on DC has become more and more important. The research progress on dendritic cells and cytokine induced killer cells for cancer treatment is reviewed in this article.
作者 谢裕安
出处 《中国肿瘤》 CAS 2005年第10期663-666,共4页 China Cancer
关键词 树突状细胞 细胞因子诱导杀伤细胞 肿瘤免疫 dendritic cells cytokine induced killer cells tumor immunity
  • 相关文献

参考文献7

二级参考文献42

  • 1Jae Ho Lee 1, Ja Lok Ku 1, Young Jin Park 1,2 , Kuhn Uk Lee 2, Woo Ho Kim 3 and Jae Gahb Park 1,2.Establishment and characterization of four human hepatocellular carcinoma cell lines containing hepatitis B virus DNA[J].World Journal of Gastroenterology,1999,5(4):17-23. 被引量:28
  • 2童春容,陆道培,丘镜莹,何萁.细胞因子诱导的杀伤细胞对慢性髓性白血病细胞的体外净化作用[J].中国实验血液学杂志,1996,4(3):314-318. 被引量:13
  • 3陈复兴 刘军权 等.人PBMC经数种活化剂活化后的表型变化[J].中国肿瘤生物治疗杂志,1999,6:186-187.
  • 4陈复兴 刘军权 等.抗人CD3单克隆抗体体外诱导T细胞和肿瘤浸润性淋巴细胞增殖的研究[J].南京部队医药,1994,5:15-17.
  • 5[1]Peck K, Sher YP, Shih JY, et al. Detection and quantitation of circulating cancer cells in the peripheral blood of lung cancer patients[J]. Cancer Res, 1998, 58(13) :2761
  • 6[2]Funaki NO, Tanaka J, Ohshio G, et al. Cytokeratin 20 mRNA in peripheral venous blood of colorectal carcinoma patients[J]. Br J Cancer. 1998, 77(8) :1327
  • 7[3]Banchereau J, Steinman R. Dendritic cells and the control of immunity[J]. Nature, 1998, 392:245
  • 8[4]Avigan D. Dendritic cells: development, function and potential use for cancer immunotherapy[J]. Blood Rev, 1999,13(1):51
  • 9[5]Schmidt-Wolf I, Negrin R, Kiem H, et al. Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity[J3. J Exp Med,1991, 174:139
  • 10[6]Marten A, Ziske C, Schottker B, et al. Interactions between dendritic cells and cytokine-induced killer cells lead to an activation of both populations[J]. J Immunol, 2001, 24(6) :502

共引文献331

同被引文献100

引证文献14

二级引证文献89

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部